Guidance

Influenza: treatment and prophylaxis using anti-viral agents

Guidance on how to manage influenza (flu) using anti-viral agents.

Documents

Guidance on use of antiviral agents for the treatment and prophylaxis of seasonal influenza

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

The use of antivirals for the treatment and prophylaxis of influenza: summary of guidance for healthcare professionals

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Letter to clinicians regarding the use of antivirals in influenza

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

These documents include information on:

  • definitions
  • treatment of suspected or confirmed influenza
  • post-exposure prophylaxis
  • use of anti-virals in pregnancy, breastfeeding, hepatic or renal dysfunction
Published 23 January 2014
Last updated 8 October 2019 + show all updates
  1. Removed 'Letter to clinicians prescribing antivirals: December 2018 update'.

  2. Updated 'Guidance on use of antiviral agents for the treatment and prophylaxis of seasonal influenza'.

  3. Updated recommendations from manufacturers on the use of 2 drugs described in the document.

  4. Added additional advice for clinicians prescribing antivirals letter.

  5. Replaced guidance on use of antiviral agents with new version.

  6. Updated PHE guidance document.

  7. Updated with 2016 to 2017 guidance.

  8. Document entitled "Antiviral prescribing when A(H1N1)pdm09 influenza virus is the dominant circulating strain Update letter, January 2016" has been removed as it was specific to last season and therefore the information contained is no longer applicable.

  9. Update letter for antiviral prescribing when A(H1N1)pdm09 influenza virus is the dominant circulating strain.

  10. Updated guidance for the 2015 to 2016 flu season.

  11. This version (5.1) updates version 5.0 (October 2014) with revised guidance on choice of antivirals in severely immunocompromised individuals.

  12. The following have been uploaded; The use of antivirals for the treatment and prophylaxis of influenza: summary of guidance for healthcare professionals; Letter to clinicians regarding the use of antivirals in influenza

  13. Updated guidance.

  14. First published.